Skip to main content
. 2022 Nov 17;9(11):1766. doi: 10.3390/children9111766

Table 1.

General characteristics of the population divided into three groups according to the hemodynamic status during the first five days of life: no hemodynamic impairment (NoHI group), isolated high blood pressure (HighBP group), and cardiac failure (CF group). Data are presented as median values and 1st and 3rd quartiles or n (%). * Outcomes calculated in survivors.

NoHI HighBP CF
n = 15 n = 12 n = 15
Pregnancy
 Threatened preterm labor, n (%) 3 (20) 3 (25) 2 (13)
 Prenatal death of the donor twin, n (%) 8 (53) 1 (8) 0 (0)
 Gestational diabetes, n (%) 0 (0) 1 (8) 1 (7)
 Pre-eclampsia, n (%) 0 (0) 1 (8) 0 (0)
 Premature rupture of membranes, n (%) 2 (13) 2 (17) 0 (0)
 Antenatal corticosteroid therapy, n (%) 9 (60) 10 (83) 10 (67)
Birth
 Gestational age, median (Q1–Q3) 33 (32–34) 29 (28–30) 29 (28–31)
 Male, n (%) 5 (33) 7 (58) 7 (47)
 Weight (g), median (Q1–Q3) 1800 (1665–2082) 1293 (1168–1533) 1265 (1150–1607)
 Weight (percentile), median (Q1–Q3) 53 (31–77) 71 (55–79) 66 (34–75)
 % difference of weight with the twin, median (Q1–Q3) 20.1 (8.7–28) 22.8 (11.8–30.1) 18.2 (12.9–22.8)
 APGAR score
1 min, median (Q1–Q3) 8 (8–9) 6 (4–8) 5 (2–6)
5 min, median (Q1–Q3) 10 (9–10) 9 (8–9) 8 (4–9)
 Umbilical cord pH, median (Q1–Q3) 7.36 (7.31–7.39) 7.37 (7.36–7.39) 7.30 (7.26–7.37)
Hemodynamic morbidity
 High systolic blood pressure, n (%) 0 (0) 12 (100) 15 (100)
 Ventricular hypertrophy, n (%) 2/11 (33) 12 (100) 15 (100)
 Patent ductus arteriosus requiring treatment, n (%) 0 (0) 0 (0) 1 (7)
Other neonatal morbidities
 Hemodilution, n (%) 0 (0) 1 (8) 4/15 (27)
 Bronchopulmonary dysplasia, n (%) * 0 (0) 2 (17) 1/9 (11)
 Severe intraventricular hemorrhage (>2), n (%) 0 (0) 1 (8) 3/15 (20)
 Periventricular leukomalacia, n (%) * 0 (0) 1 (8) 4/9 (44)
 Secondary sepsis, n (%) * 2 (13) 2 (17) 4/9 (44)
 Necrotizing enterocolitis, n (%) * 1 (7) 1 (8) 0/9 (0)
 Acute kidney injury, n (%) 0 (0) 3 (25) 14/15 (93)
Death
 Death in the first five days of life, n (%) 0 (0) 0 (0) 6 (40)
 Age at death (hours), median (Q1–Q3) 47 (26–65)